8,000 pharmaceutical scientists to explore breakthrough research, technology

ARLINGTON, Va. More than 8,000 pharmaceutical scientists from around the world will gather in Denver, Oct. 21-25 at the 2001 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition to learn, network and explore new scientific research and technologies.

"Scientists at this meeting will present more than 2,000 contributed papers featuring important scientific findings,"said AAPS President Ronald T. Borchardt, Ph.D. "The meeting will focus on such topics as gene therapy, pharmacogenomics and its impact on drug discovery and marketing, clinical trials in children, role of drug transporters in the brain, and emerging pharmaceutics strategies for more efficient drug candidate identification."

Topics to be presented include:
Genomics: Impact on Drug Discovery and Marketing in the New Millennium
Pediatric Rule: Mandating Clinical Trials in Children: Is it Time to End the Guesswork in Dose Selection for Children?
Analysis and Pharmaceutical Quality of Biotechnology Derived Products: From Development to Production
Current Oversight of Gene TherapyIs It Adequate?
The Successes and Challenges of Bioinformatics and Pharmacogenomics in Drug Discovery and Development
Emerging Pharmaceutics Strategies for More Efficient Drug Candidate Identification
Pharmacokinetics and Pharmacodynamics Issues in the Elderly
Penetration of Drugs and Macromolecules in Solid Tumors
Role of Drug Transporters in the Brain
Novel Tools to Study the Mechanisms, Expression and Regulation of Drug Transporters

The meetings opening session features keynote speaker Donald P. Francis, M.D., D.Sc., President and Co-Founder of VaxGen, Inc. Dr. Francis is one of the worlds most widely recognized scientists in the field of AIDS research. His efforts to call attention to the AIDS threat and warn of the inadequacy of the public health response were chronicled in the book and movie And The Band Played On, journalist Randy Shilts

Contact: Debbie Werfel
American Association of Pharmaceutical Scientists

Page: 1 2

Related medicine news :

1. Benign separation process being advanced for pharmaceutical industry
2. NYUS Duster cautions against FDA approval of race-based pharmaceutical
3. Biopharmaceutical manufacturing efficiencies signal reduced healthcare costs
4. Physicians have mixed opinions about consumer-targeted pharmaceutical ads
5. Medical residents need training to interact with pharmaceutical representatives
6. UK industry is the loser from parallel trade in pharmaceuticals
7. Nonprofit pharmaceutical seeks drug approval next year
8. Preventing stray chemicals in food, pharmaceutical and industrial products
9. The pharmaceutical industry as political player
10. Distortion and lack of openness - Information provision from the pharmaceutical industry
11. Former insider hits out at FDAs links with pharmaceutical industry

Post Your Comments:

(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Compliance and Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual ... Innovation to Action Award. , The Innovation to Action Award, a USAID ...
(Date:9/19/2017)... ... 2017 , ... MelaKids, a Laredo-based company, has introduced a new concept for ... Nature gives us a full supply of melanin – in the back of the ... glare-reducing pigment; however, around the age of thirty, we develop a yellow-brown pigment in ...
(Date:9/19/2017)... ... 19, 2017 , ... The Workgroup for Electronic Data Interchange (WEDI) , ... in healthcare information exchange and a trusted advisor to the U.S. Department of Health ... entitled Barriers to Adoption of the ERA and EFT Transactions . , ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the ... industry itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. ... natural alkaline water technologies, water filtration systems, and consumer education. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone ... the first in the U.S. to incorporate magnesium, a critical property for bone ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)...  Medical professionals are expected to continuously ... their patients. Medical simulations offer clinicians the ... Simulation provides a safe method for teaching ... refine techniques and build confidence, without putting ... such as augmented reality, will now provide ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology:
Cached News: